20 Microns [20MICRONS] vs Chemo-Pharma [CPL] Detailed Stock Comparison

20 Microns

NSE
Loading...

Chemo-Pharma

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: 20 Microns wins in 12 metrics, Chemo-Pharma wins in 7 metrics, with 0 ties. 20 Microns appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric20 MicronsChemo-PharmaBetter
P/E Ratio (TTM)12.9512.19Chemo-Pharma
Price-to-Book Ratio1.852.5720 Microns
Debt-to-Equity Ratio37.9744.7020 Microns
PEG Ratio-2.340.6220 Microns
EV/EBITDA8.0913.9120 Microns
Profit Margin (TTM)6.60%11.11%Chemo-Pharma
Operating Margin (TTM)10.82%9.62%20 Microns
EBITDA Margin (TTM)10.82%9.62%20 Microns
Return on Equity14.37%20.97%Chemo-Pharma
Return on Assets (TTM)8.73%11.26%Chemo-Pharma
Free Cash Flow (TTM)$-448.94M$41.66MChemo-Pharma
Dividend Yield0.45%N/AN/A
1-Year Return-23.64%-16.80%Chemo-Pharma
Price-to-Sales Ratio (TTM)0.861.4220 Microns
Enterprise Value$9.38B$4.67B20 Microns
EV/Revenue Ratio1.011.6020 Microns
Gross Profit Margin (TTM)45.44%29.30%20 Microns
Revenue per Share (TTM)$263$5120 Microns
Earnings per Share (Diluted)$17.40$5.6620 Microns
Beta (Stock Volatility)0.740.23Chemo-Pharma
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

20 Microns vs Chemo-Pharma Stock Performance Analysis

Loading Price Chart...

20 Microns
Chemo-Pharma
20 Microns Stock Overview | Chemo-Pharma Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
20 Microns0.08%1.30%1.29%-1.14%23.05%-2.74%
Chemo-Pharma-1.29%-1.72%-5.21%-9.81%-14.81%-42.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
20 Microns-23.64%117.91%709.60%821.32%705.91%1,885.60%
Chemo-Pharma-16.80%308.26%136.70%650.84%1,203.71%1,203.71%

News Based Sentiment: 20 Microns vs Chemo-Pharma

20 Microns

News based Sentiment: MIXED

September brought a blend of positive and negative developments for 20 Microns. The dividend announcement and trade show participation are encouraging, but are counterbalanced by fluctuating share prices, negative forecasts, and shifts in institutional ownership. This creates a mixed investment picture requiring careful consideration.

View 20 Microns News Sentiment Analysis

Chemo-Pharma

News based Sentiment: NEUTRAL

The month saw share price fluctuations and a discrepancy in reported market capitalization, but no major strategic shifts or financial results were announced. These developments are noteworthy but don't fundamentally alter the investment outlook.

View Chemo-Pharma News Sentiment Analysis

Performance & Financial Health Analysis: 20 Microns vs Chemo-Pharma

Metric20MICRONSCPL
Market Information
Market Cap i₹7.97B₹4.08B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i97,93835,247
90 Day Avg. Volume i118,74634,367
Last Close₹230.51₹66.75
52 Week Range₹158.20 - ₹321.00₹66.00 - ₹128.00
% from 52W High-28.19%-47.85%
All-Time High₹348.00 (Aug 19, 2024)₹128.00 (Jan 06, 2025)
% from All-Time High-33.76%-47.85%
Growth Metrics
Quarterly Revenue Growth0.07%0.08%
Quarterly Earnings Growth-0.06%0.34%
Financial Health
Profit Margin (TTM) i0.07%0.11%
Operating Margin (TTM) i0.11%0.10%
Return on Equity (TTM) i0.14%0.21%
Debt to Equity (MRQ) i37.9744.70
Cash & Liquidity
Book Value per Share (MRQ)₹121.68₹26.86
Cash per Share (MRQ)₹8.87₹1.01
Operating Cash Flow (TTM) i₹271.62M₹277.99M
Levered Free Cash Flow (TTM) i₹623.76M₹313.23M
Dividends
Last 12-Month Dividend Yield i0.45%N/A
Last 12-Month Dividend i₹1.25₹0.00

Valuation & Enterprise Metrics Analysis: 20 Microns vs Chemo-Pharma

Metric20MICRONSCPL
Price Ratios
P/E Ratio (TTM) i12.9512.19
Forward P/E iN/AN/A
PEG Ratio i-2.340.62
Price to Sales (TTM) i0.861.42
Price to Book (MRQ) i1.852.57
Market Capitalization
Market Capitalization i₹7.97B₹4.08B
Enterprise Value i₹9.38B₹4.67B
Enterprise Value Metrics
Enterprise to Revenue i1.011.60
Enterprise to EBITDA i8.0913.91
Risk & Other Metrics
Beta i0.740.23
Book Value per Share (MRQ) i₹121.68₹26.86

Financial Statements Comparison: 20 Microns vs Chemo-Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)20MICRONSCPL
Revenue/Sales i₹2.47B₹697.42M
Cost of Goods Sold i₹1.35B₹493.08M
Gross Profit i₹1.12B₹204.34M
Research & Development iN/AN/A
Operating Income (EBIT) i₹267.54M₹67.12M
EBITDA i₹276.00M₹79.31M
Pre-Tax Income i₹228.70M₹55.13M
Income Tax i₹60.05M₹12.13M
Net Income (Profit) i₹168.64M₹42.99M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)20MICRONSCPL
Cash & Equivalents i₹312.98M₹12.05M
Total Current Assets i₹3.75B₹2.51B
Total Current Liabilities i₹2.19B₹1.17B
Long-Term Debt i₹321.53M₹109.50M
Total Shareholders Equity i₹4.34B₹1.49B
Retained Earnings i₹3.39BN/A
Property, Plant & Equipment i₹254.97M₹144.04M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)20MICRONSCPL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric20MICRONSCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i97,93835,247
Average Daily Volume (90 Day) i118,74634,367
Shares Outstanding i35.29M57.55M
Float Shares i14.40M17.06M
% Held by Insiders i0.56%0.70%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: 20 Microns vs Chemo-Pharma

Metric20MICRONSCPL
Last 12-Month Dividend i₹1.25₹0.00
Last 12-Month Dividend Yield i0.45%N/A
3-Year Avg Annual Dividend i₹1.08₹0.00
3-Year Avg Dividend Yield i0.56%N/A
3-Year Total Dividends i₹3.25₹0.00
Ex-Dividend DateJul 24, 2025N/A